Larimar Therapeutics, Inc. LRMR
2.39 USD +0.07 (+3.02%)
Nov 6, 2026, 1:20 PM EST
2.30 Day range 2.48
1.92 52-week range 6.42
- YTD
- -37.27%
- 1 year
- -31.12%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 172.50M | 90.89M | 41.76M | 36.53M | 50.47M | |
| 154.22M | 73.28M | 27.67M | 24.25M | 38.40M | |
| 18.27M | 17.61M | 14.09M | 12.28M | 12.07M | |
| -172.50M | -90.89M | -41.76M | -36.53M | -50.47M | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| -2.27 | -1.32 | -0.84 | -1.37 | -2.95 | |
| -2.27 | -1.32 | -0.84 | -1.37 | -2.95 | |
| -2.27 | -1.32 | -0.84 | -1.37 | -2.95 | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| -165.67M | -80.60M | -36.95M | -35.35M | -50.64M | |
| 72.95M | 61.26M | 43.90M | 25.76M | 17.16M | |
| 72.95M | 61.26M | 43.90M | 25.76M | 17.16M |